Iran Strikes Fujairah, Europe Sells Off, and What It Means for 12 Active Research Subjects

The last time we saw a geopolitical supply shock combine with already-elevated bond yields and a VIX moving above 18, conditions loosely resembled the China devaluation and oil price dislocation of late 2015 into early 2016. That parallel is imperfect. Back then the threat was demand destruction and collapsing commodity prices, not a physical attack on a critical oil transit hub. But the pattern of regional equity divergence, with some markets shrugging it off while others sold hard, rhymes in a useful way. In 2015-2016, the S&P 500 ultimately round-tripped, energy bottomed first, and the rebound was led by high-yield and emerging markets once policy stabilized. The key difference today is on the supply side: oil risk premiums are rising alongside bond yields, creating a simultaneous inflation-and-valuation squeeze that the 2015-2016 episode lacked. Whether the 2015-2016 resolution script replays depends heavily on what happens next in the Strait of Hormuz corridor and, critically, whether central banks treat the oil shock as transitory or as a reason to hold rates higher for longer.

What Happened This Tuesday Morning

Iran attacked the port of Fujairah, a vital oil hub sitting just outside the Strait of Hormuz. India condemned the strike and called for de-escalation. This is now day 67 of the Iran conflict, and the Hormuz crisis is deepening, not stabilizing. Fujairah is one of the world's largest bunkering ports and a key bypass route for oil shipments that want to avoid transiting the Strait directly. An attack there raises the risk premium on all Gulf-origin crude, even if the physical damage turns out to be limited.

Oil prices, after initially jumping on the news, gave back some gains this morning. The headline reads "Oil Prices Slide but Remain Elevated as Middle East Tensions Escalate," which tells you the market is trying to price in two opposing forces: the geopolitical risk premium pulling prices up, and uncertainty about whether this escalates further or fizzles. As I discussed in Hormuz Tensions, Asian Tech Rallies, and a Week Ahead Preview, I have been watching this chokepoint dynamic for days.

HSBC reported that profits were hit by both a fraud-related case and Middle East war exposure. The bank is setting aside significant provisions tied to the conflict. This is a real-world earnings impact, not a hypothetical risk, though it is worth noting the impairment figure reflects multiple issues, not solely the Iran situation.

Meanwhile, Trump's Germany troop cuts are testing the limits of NATO's efforts to keep the US engaged in European defense. This compounds the pressure on European equities: markets already reeling from energy import vulnerability are now also pricing in defense uncertainty. When your energy security depends on Middle East stability and your military umbrella is fraying simultaneously, the risk premium on European assets widens.

European equities took the worst of it. The Euro Stoxx 50 fell 2.0%, France's CAC 40 dropped 1.71%, Spain's IBEX fell 2.39%, and Germany's DAX declined 1.24%. The country ETFs reflected this clearly: EWP (Spain) down 3.07%, EWI (Italy) down 2.46%, EWQ (France) down 2.42%, EWG (Germany) down 2.01%. Europe's proximity to the conflict zone, its energy import dependence, and now growing questions about its security architecture make it structurally more sensitive to Middle East escalation than any other developed market bloc.

A notable counterpoint to the bearish European narrative: UniCredit reported Q1 profits that smashed forecasts and raised its 2026 target to over 11 billion euros. European bank fundamentals remain strong even as the macro backdrop deteriorates. This divergence between earnings strength and index-level selling suggests the European selloff is driven more by macro risk repricing than by deteriorating corporate health. That distinction matters for anyone evaluating whether this is a buying opportunity or the start of something worse.

Alphabet kicked off a six-part euro-denominated debt offering, a sign that major US corporates still see European capital markets as functional and attractive despite the volatility. That is a quiet vote of confidence in European credit markets even as equities struggle.

In the US, the picture was more nuanced. The S&P 500 slipped 0.41%, the Dow fell a more noticeable 1.13%, and the Nasdaq barely moved at negative 0.19%. The VIX rose 7.65% to 18.29, which signals rising hedging demand but is not panic territory. Bond yields climbed, with the 10-year Treasury at 4.446% (up 1.55%) and the 30-year touching 5.025% (up 1.19%). Rising yields alongside falling equities is the uncomfortable combination that makes diversification harder. The Dow's sharper decline relative to the Nasdaq reflects the index's heavier weighting toward industrials and financials, sectors more directly exposed to geopolitical disruption and rate sensitivity.

One standout: South Korea's KOSPI jumped 5.12%, and the EWY ETF gained 0.98% even on a broadly red day. Japan's Nikkei rose 0.38%. East Asian semiconductor-heavy markets continue to dance to their own beat, driven by AI infrastructure demand that operates largely independent of Middle East oil dynamics.

This Is Becoming a Rates-and-Valuation Shock, With Europe as the First Casualty

Let me state the central thesis plainly: the Fujairah attack is no longer just an oil headline. When oil risk premiums feed into inflation expectations, and inflation expectations push bond yields higher, and higher yields compress equity valuations, you get a transmission chain that reaches every asset class. Europe is the first casualty because it sits at the intersection of energy dependence, defense uncertainty, and rate sensitivity. But if the 30-year Treasury stays above 5%, the pressure will spread.

Here is a simple scenario framework:

How This Connects to the 12 Active Research Subjects

Rather than walking through each name in isolation, let me group them by how they respond to the current regime. A quick reminder: everything below is observational research output, not personalized investment advice. Please consult an authorized financial advisor before making any investment decisions.

AI and Growth Winners: Largely Insulated

MU (Micron Technology) is currently up 6.31% from entry. The memory cycle thesis continues to benefit from insatiable AI infrastructure demand. Today's geopolitical noise is largely irrelevant to Micron's core business. What matters for MU is data center capex budgets, and nothing in today's headlines changes that trajectory. (Note: given significant appreciation from historical levels, the current price reflects the strong AI-driven cycle the thesis anticipated.)

MSFT (Microsoft) is essentially flat from the new entry at negative 0.2%. I recently closed a prior MSFT research entry at a positive 9.19% outcome, triggered by a trailing stop after the stock pulled back from a peak gain of 15.9%. The re-entry at a higher price point is treading water so far. Azure cloud growth remains the core driver, and today's modest Nasdaq decline of 0.19% shows large-cap tech holding up well against the geopolitical backdrop.

META (Meta Platforms) is down 3.09% from entry. The thesis centers on META trading at a meaningful discount to mega-cap peers despite superior profitability metrics. Today's tech resilience relative to broader markets is consistent with the quality factor the thesis depends on. With the VIX at 18.29, we are not in a fear environment severe enough to drag all growth names down indiscriminately.

ADBE (Adobe) has moved up 3.47% from entry. The thesis review gave this a full 5/5 health score last week. Adobe's deep discount to its 52-week high, combined with strong free cash flow and margins, fits the pattern I have identified: dominant software leaders bought at steep discounts tend to deliver the strongest absolute returns. Early signs are encouraging.

EWT (Taiwan ETF) is up 2.63% from entry. Taiwan's semiconductor supply chain continues to benefit from AI capex. The ETF gained today while most global markets declined, showing the relative strength the thesis anticipated. The standing concern remains geopolitical risk around Taiwan and China, which is an ever-present background factor rather than an acute one today.

EWY (South Korea ETF) is the strongest performer among active subjects at up 7.39% from entry. South Korea's KOSPI gained 5.12% today, a remarkable move driven by the memory and semiconductor cycle powering Samsung and SK Hynix. The entry confidence on this was only 42%, well below the 55% threshold where historically all entries in this research set have lost money. The fact that this is working despite low confidence is a useful data point, though I would caution against drawing broad conclusions from a single outcome. Minor concerns remain around trade tension risks.

Defensives Failing to Defend

LLY (Eli Lilly) is up a modest 0.48% from entry. The GLP-1 revenue story remains the primary driver. Healthcare showed relative resilience today. As I noted in Week 7: Why Healthcare Longs Failed, International ETFs Outperformed, and How Confidence Weighting Changes Everything, I have historically struggled with healthcare picks. LLY's growth profile is different from the defensive healthcare names that disappointed in past research sets, but the entry confidence of 65% puts it in a zone that demands close watching.

PFE (Pfizer) is down 2.59% from entry. This is the defensive, high-yield pharma play built around valuation floor and cash flow. The thesis review says 5/5 health, but the negative delta is worth noting honestly. Pfizer's slight decline is consistent with the broader market weakness rather than company-specific news. My research learnings flag that defensive single-stock picks labeled "low risk" can still suffer drawdowns in sectors with binary risks.

AMGN (Amgen) is the weakest active subject at negative 7.74%. I will be honest: this has not played out. My research history shows a pattern where healthcare picks entered primarily for "portfolio diversification" rather than standalone opportunity quality tend to underperform. That learning is directly relevant here.

PEP (PepsiCo) is down 1.57% from entry. Consumer staples declined modestly today, which is unusual since staples typically hold up better during geopolitical stress. The thesis points to PEP's earnings growth and dividend yield as anchors. But the negative delta across PEP and other defensive names suggests something important: in a regime where yields are rising because of supply-side inflation, even "safe" equities lose their appeal because bonds become increasingly competitive on a yield basis. That is the dynamic playing out right now.

The bottom line on defensives: they are not defending. In a world where the 30-year yield is above 5%, the traditional playbook of rotating into staples, pharma, and utilities during stress breaks down. Cash and short-duration bonds compete directly with dividend yields, and the "safety bid" that defensives usually attract gets diluted.

Financials: Mixed Rate Signals

GS (Goldman Sachs) is down 2.45% from entry. Financials sold off today, but Goldman's thesis is tied to improving capital markets activity and deal flow. Rising bond yields (the 10-year at 4.446%) are a double-edged sword for banks: good for net interest margins, potentially bad for loan demand and mark-to-market losses. HSBC's war-related impairment is a reminder that Middle East exposure creates direct earnings risk for global banks. The UniCredit earnings beat, however, shows that the fundamental picture for banks is not uniformly negative.

BAC (Bank of America) is the stronger of the two financials at up 5.69% from entry. The steepening yield curve continues to support BAC's net interest margin thesis. However, with the stock approaching its base case target, the remaining upside has compressed. The 5-year yield rising to 4.093% today (up 1.79%) is directionally supportive, but risk-reward is less attractive now than at entry.

Two Recent Closes Worth Noting

I closed the NVDA research subject on May 1 with a positive observed outcome of 5.80%. The trailing stop triggered after the stock pulled back from a peak gain of 14.8%. Similarly, the prior MSFT entry closed at positive 9.19% after reaching a peak of 15.9%. Both were trailing stop exits. In my limited sample (roughly a dozen trailing stop exits to date), stops typically capture 60-70% of peak gains. In NVDA's case, it captured about 39%, which is below average and reinforces the finding that trailing stops on volatile names may be set too tight.

The Energy Question

Energy was the best-performing US sector today, which makes intuitive sense given the Fujairah attack headline. But my research history carries a specific and well-documented lesson: energy positions entered during geopolitical-driven spikes have a 100% loss rate in this research set (across four entries). Every single one mean-reverted within weeks as the geopolitical premium faded faster than the market initially expected. The sample size is small enough that I would not treat this as a universal law, but it is a consistent enough pattern that I am not currently studying any energy-specific subjects, by design.

What I Am Watching Next

The interplay between rising Treasury yields and equity valuations is the thread I keep pulling on. The 30-year yield at 5.025% is a significant level. If yields keep climbing because geopolitical oil risk feeds into inflation expectations, it creates a much more difficult environment for all equity valuations, including the tech and growth names that have held up well so far.

The question is whether the Fujairah attack represents an escalation with staying power or a contained event that gets absorbed. The "day 67" framing from the headlines suggests this conflict has duration, not just intensity. Markets will tell us over the next 48 hours whether they are pricing in a longer disruption or treating this as another spike to fade.

For the research subjects specifically, the biggest open question is whether the defensive names (PEP, PFE, AMGN) will start doing their job as portfolio ballast, or whether rising yields continue to override the safety bid. So far, the evidence is clear: in a supply-side inflation shock, defensives have not defended. That is an important finding regardless of what happens next.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects discussed (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.